Stock Research: SI-BONE

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

SI-BONE

NasdaqGM:SIBN US8257041090
84
  • Value
    64
  • Growth
    97
  • Safety
    Safety
    32
  • Combined
    82
  • Sentiment
    70
  • 360° View
    360° View
    84
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

SI-BONE, Inc. is a medical device company focused on solving musculoskeletal disorders of sacropelvic anatomy; it specializes in minimally invasive surgical implant systems for sacroiliac joint dysfunction, pelvic fixation, and pelvic fractures. Its main businesses include iFuse, iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite implant systems. The company operates within the United States. In the last fiscal year, the company had a market cap of $727 million, profits of $132 million, revenue of $167 million, and 349 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 84 (better than 84% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock SI-BONE are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for SI-BONE. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 97% of competitors in the same industry. The consolidated Safety Rank at 64 means that the company has a financing structure that is safer than 64% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 70, which means that professional investors are more optimistic about the stock than for 70% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 32, meaning that the share price of SI-BONE is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 68% of alternative stocks in the same industry. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 33 25 15
Growth
97 67 100 9
Safety
Safety
64 50 39 67
Sentiment
70 47 73 30
360° View
360° View
84 44 80 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
86 81 84 71
Opinions Change
50 50 50 50
Pro Holdings
n/a 46 60 18
Market Pulse
54 25 48 47
Sentiment
70 47 73 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 33 25 15
Growth
97 67 100 9
Safety Safety
64 50 39 67
Combined
82 52 62 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
30 30 30 20
Price vs. Earnings (P/E)
38 34 24 31
Price vs. Book (P/B)
42 36 30 30
Dividend Yield
1 1 1 1
Value
32 33 25 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
86 66 65 63
Profit Growth
74 84 76 15
Capital Growth
79 18 89 13
Stock Returns
77 53 100 37
Growth
97 67 100 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
68 65 46 57
Refinancing
71 65 65 69
Liquidity
18 15 24 28
Safety Safety
64 50 39 67

Similar Stocks

Discover high‑ranked alternatives to SI-BONE and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.